OUAT Microbiology - M.Sc & Ph.D

The 2024 Nobel Prize laureates in chemistry Demis Hassabis and John Jumper developed an AI model to solve a 50-year-old problem: predicting proteins’ complex structures.

In 2020, Hassabis and Jumper presented an AI model called AlphaFold2. With its help, they have been able to predict the structure of virtually all the 200 million proteins that researchers have identified. Since their breakthrough, AlphaFold2 has been used by more than two million people from 190 countries. Among a myriad of scientific applications, researchers can now better understand antibiotic resistance and create images of enzymes that can decompose plastic.

What groundbreaking discoveries will be recognised with a Nobel Prize this year? The announcements will begin in just a few days. Learn more: https://bit.ly/2QRp4Jp

🎓✨ Congratulations to on successfully defending your PhD! Your dedication, resilience, and hard work have paid off. Here's to new beginnings and even greater accomplishments ahead!

🎓✨ Congratulations to .tanaya_ on successfully defending your PhD! Your dedication, resilience, and hard work have paid off. Here's to new beginnings and even greater accomplishments ahead!

Embrace the complexity of the process; what seems daunting now will soon become second nature

Switching off inflammatory protein leads to longer, healthier lifespans in mice.
Scientists at the Medical Research Council Laboratory of Medical Science and Imperial College London have discovered that 'switching off' a protein called IL-11  (interleukin 11) can significantly increase the healthy lifespan of mice by almost 25%.
👉The results, published in Nature, were dramatic, with mice given the anti-IL-11 drug from 75 weeks of age until death having their median lifespan extended by 22.4% in males and 25% in females. The mice lived for an average of 155 weeks, compared with 120 weeks in untreated mice.
🤞While these findings are only in mice, it raises the tantalising possibility that the drugs could have a similar effect in elderly humans. Anti-IL-11 treatments are currently in human clinical trials for other conditions, potentially providing exciting opportunities to study its effects in ageing humans in the future."

Exciting moment as our accomplished alum, Dr. Sudipta Maity, takes the stage to discuss the Bio-Entrepreneurship Ecosystem within the Biotechnology Industry Research Assistant Council, Govt of India. A passionate advocate for student-led academic innovations through BIRAC's E-YUVA scheme, Dr. Maity sparks awareness at the DBT Star College, College of Basic Science and Humanities, leaving an impact in the Diamond Jubilee Lecture Series orchestrated by IQAC. "
📢Call for E-YUVA fellowship of DBT -BIRAC is currently Open. Follow the Bellow link
https://birac.nic.in/